Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Yi-Ke-Ding
- Development stage
- Unknown
- Lead developer
- West China Hospital of Sichuan University
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Yi-Ke-Ding (also known as YKD or Yikedine) is a proprietary Traditional Chinese Medicine (TCM) preparation developed by the Department of Integrated Traditional and Western Medicine at West China Hospital, Sichuan University. It is specifically indicated for the treatment of chronic cholecystitis and cholelithiasis (gallstones). The preparation is a combination of herbal extracts, primarily including *Desmodium styracifolium* (Jin Qian Cao), *Curcuma wenyujin* (Yu Jin), and *Artemisia capillaris* (Yin Chen). Yi-Ke-Ding exerts its therapeutic effects through choleretic activity, which promotes the secretion and flow of bile, and anti-inflammatory actions that reduce gallbladder mucosal damage and wall thickening. Additionally, it possesses spasmolytic properties that help relax the biliary tract and the sphincter of Oddi, facilitating the passage of bile and small stones. It is used clinically as a hospital-made preparation (院内制剂) within the West China Hospital system to manage symptoms such as right upper quadrant pain and dyspepsia.
- Brand names
- Yi-Ke-Ding
- Other names
- YikedineYikeding
02
Targets
CXADR (Coxsackievirus and adenovirus receptor)
Beyond the preview
Go deeper on Yi-Ke-Ding.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Yi-Ke-Ding.